PreserVision AREDS 2 Formula Supplement (210 Count)

$32.61

PreserVision is the #1 recommended brand by eye doctors for people with moderate-to-advanced age-related macular degeneration. Brought to you by Bausch + Lomb the leader in AREDS eye vitamins.
The exact nutrient formula recommended by the National Eye Institute which includes lutein and zeaxanthin
The levels of antioxidants and zinc shown to be beneficial for people at risk of progression of AMD are not found in typical daily multivitamins.

PreserVision AREDS 2 Formula Supplement (210 Count)
PreserVision AREDS 2 Formula Supplement (210 Count)

$32.61

Description

Size:210 Count PreserVision AREDS 2 Formula builds on the original, clinically proven PreserVision AREDS Formula, with lutein and zeaxanthin replacing beta- carotene, based on the AREDS2 study. PreserVision AREDS 2 Formula exactly matches the nutrient formula recommended by the AMD experts at the National Eye Institute based on the AREDS2 study.

PreserVision is the #1 recommended brand by eye doctors for people with moderate-to-advanced age-related macular degeneration. Brought to you by Bausch + Lomb the leader in AREDS eye vitamins.
The exact nutrient formula recommended by the National Eye Institute which includes lutein and zeaxanthin
The levels of antioxidants and zinc shown to be beneficial for people at risk of progression of AMD are not found in typical daily multivitamins.
Completed in 2013, the Age Related Eye Disease Study 2 (AREDS2) was a five-year study conducted by the National Eye Institute (NEI) of the National Institutes of Health.

Additional information

Specification: PreserVision AREDS 2 Formula Supplement (210 Count)

Product Dimensions

Shipping Weight

UPC

Item model number

Blended Vitamin & Mineral Supplements

Brand

Reviews (0)

User Reviews

0.0 out of 5
0
0
0
0
0
Write a review

There are no reviews yet.

Be the first to review “PreserVision AREDS 2 Formula Supplement (210 Count)”

Your email address will not be published. Required fields are marked *

Logo
Login/Register access is temporary disabled